Research and Development Accruals (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended |
|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2017 |
|
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
| Consulting agreement, expense recognized | $ 0.0 | $ 0.0 |
| Minimum | ||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
| Consulting agreement, contingent liability | 1.5 | |
| Maximum | ||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
| Consulting agreement, contingent liability | $ 4.0 |
| X | ||||||||||
- Definition Represents consulting agreement liability if certain future contingent events occur. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|